Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children

被引:4
|
作者
Freeman, G. [1 ]
Ng, S. [2 ]
Perera, R. A. P. M. [3 ,4 ]
Fang, V. J. [1 ]
Ip, D. K. M. [1 ]
Leung, G. M. [5 ]
Peiris, J. S. M. [3 ,4 ]
Cowling, B. J. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China
[2] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Publ Hlth Lab Sci, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Li Ka Shing Fac Med, Div Community Med & Publ Hlth Practice, Hong Kong, Hong Kong, Peoples R China
来源
EPIDEMIOLOGY AND INFECTION | 2015年 / 143卷 / 03期
关键词
Immunization (vaccination); influenza; serology; statistics; PROTECTIVE EFFICACY; PANDEMIC INFLUENZA; ANTIBODY-RESPONSE; IMMUNE-RESPONSES;
D O I
10.1017/S0950268814000855
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We examined factors affecting the immunogenicity of trivalent inactivated influenza vaccination (TIV) in children using the antibody titres of children participating in a Hong Kong community-based study. Antibody titres of strains included in the 2009-2010 northern hemisphere TIV [seasonal A(H1N1), seasonal A(H3N2) and B (Victoria lineage)] and those not included in the TIV [2009 pandemic A(H1N1) and B (Yamagata lineage)] were measured by haemagglutination inhibition immediately before and 1 month after vaccination. Multivariate regression models were fitted in a Bayesian framework to characterize the distribution of changes in antibody titres following vaccination. Statistically significant rises in geometric mean antibody titres were observed against all strains, with a wide variety of standard deviations and correlations in rises observed, with the influenza type B antibodies showing more variability than the type A antibodies. The dynamics of antibody titres after vaccination can be used in more complex models of antibody dynamics in populations.
引用
收藏
页码:540 / 549
页数:10
相关论文
共 50 条
  • [31] Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children
    Halperin, SA
    Smith, B
    Mabrouk, T
    Germain, M
    Trépanier, P
    Hassell, T
    Treanor, J
    Gauthier, R
    Mills, EL
    VACCINE, 2002, 20 (7-8) : 1240 - 1247
  • [32] Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized study
    Vesikari, Timo
    Nauta, Jos
    Lapini, Giulia
    Montomoli, Emanuele
    van de Witte, Serge
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 92 : 29 - 37
  • [33] Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation
    Esposito, Susanna
    Salvini, Filippo
    Menni, Francesca
    Scala, Alessia
    Salvatici, Elisabetta
    Manzoni, Francesca
    Riva, Enrica
    Giovannini, Marcello
    Principi, Nicola
    VACCINE, 2013, 31 (45) : 5149 - 5151
  • [34] Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children
    Soedjatmiko, Soedjatmiko
    Medise, Bernie Endyarni
    Gunardi, Hartono
    Sekartini, Rini
    Satari, Hindra Irawan
    Hadinegoro, Sri Rezeki
    Bachtiar, Novilia Sjafri
    Sari, Rini Mulia
    VACCINE, 2018, 36 (16) : 2126 - 2132
  • [35] Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia
    Brydak, LB
    Rokicka-Milewska, R
    Machala, M
    Jackowska, T
    Sikorska-Fic, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (02) : 125 - 129
  • [36] EVALUATION OF SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF INACTIVATED CHROMATOGRAPHIC INFLUENZA VACCINE DURING OBSERVATIONS OF SCHOOL-CHILDREN
    VASILYEVA, RI
    OSIDAK, LV
    BICHURINA, MA
    MUKHINA, LP
    CHUDINA, LV
    MALEVANNY, IN
    FRIDMAN, EA
    SIROTENKO, EA
    ZYKOV, MP
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1982, (04): : 96 - 98
  • [37] IMMUNOGENICITY OF INACTIVATED TRIVALENT INFLUENZA SPLIT-VACCINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIES
    Baranova, M. M.
    Muravyeva, N. V.
    Belov, B. S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S185 - S186
  • [38] Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Beran, Jiri
    Peeters, Mathieu
    Dewe, Walthere
    Raupachova, Jolana
    Hobzova, Lenka
    Devaster, Jeanne-Marie
    BMC INFECTIOUS DISEASES, 2013, 13
  • [39] Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
    Giezeman, K. M.
    Nauta, J.
    de Bruijn, I. A.
    Palache, A. M.
    VACCINE, 2009, 27 (18) : 2414 - 2417
  • [40] Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Jiří Beran
    Mathieu Peeters
    Walthère Dewé
    Jolana Raupachová
    Lenka Hobzová
    Jeanne-Marie Devaster
    BMC Infectious Diseases, 13